Compare $CARL vs $CV | Chartloom

Compare

$CARL vs $CV

Carlsmed Inc · CapsoVision Inc

CARL

Carlsmed Inc

CapsoVision Inc

Compare $CARL vs $CV

Comparing Carlsmed Inc and CapsoVision Inc

CARLCarlsmed Inc

CVCapsoVision Inc

CARLCarlsmed Inc

Market cap

$392M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.18x

Rev growth (TTM)

16.1%

YTD performance

24.0%

52W performance

4.3%

FCF yield

-9.1%

CVCapsoVision Inc

Market cap

$329M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

18.89x

Rev growth (TTM)

-31.7%

YTD performance

-35.6%

52W performance

43.3%

FCF yield

-8.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CARL

Detailed metrics comparison

CARL

Carlsmed Inc

CapsoVision Inc

Market Cap

CARL$392M

CV$329M

Enterprise Value

CARL$361M

CV$320M

Price

CARL$14.42

CV$6.59

P/E Ratio

CARLN/A

CVN/A

P/S Ratio

CARL6.19x

CV23.70x

EV/Sales

CARL5.70x

CV23.05x

EV/EBITDA

CARL0.00x

CV0.00x

P/B Ratio

CARL4.62x

CV24.94x

P/FCF Ratio

CARLN/A

CVN/A

EV/FCF

CARL-10.12x

CV-11.48x

PEG Ratio

CARLN/A

CVN/A

Forward P/E (NTM)

CARLN/A

CVN/A

Forward P/S (NTM)

CARL4.18x

CV18.89x

Revenue (TTM)

CARL$63M

CV$14M

Revenue Growth (YoY)

CARL16.1%

CV-31.7%

Forward Rev Growth

CARL40.9%

CV33.3%

Gross Margin (TTM)

CARL76.6%

CV50.9%

Operating Margin (TTM)

CARL0.0%

CV0.0%

EBITDA Margin (TTM)

CARL-60.4%

CV-215.5%

Net Margin (TTM)

CARL-57.4%

CV-214.7%

FCF Margin (TTM)

CARL-56.4%

CV-200.8%

Net Income (TTM)

CARL$-36M

CV$-30M

FCF (TTM)

CARL$-36M

CV$-28M

EPS (TTM)

CARL-$1.34

CV-$0.60

ROE (TTM)

CARL-3806.0%

CV-17785.0%

ROA (TTM)

CARL-2896.0%

CV-13507.0%

ROIC (TTM)

CARL-3278.0%

CV-17785.0%

Cash

CARL$46M

CV$9M

Debt

CARL$15M

CV$0

Net Cash/Debt

CARL$31M

CV$9M

Current Ratio (TTM)

CARL8.84x

CV3.35x

Quick Ratio (TTM)

CARL8.32x

CV2.31x

Debt/Equity (TTM)

CARL0.18x

CV0.00x

Debt/Assets (TTM)

CARL0.0%

CV0.0%

Interest Coverage (TTM)

CARLN/A

CVN/A

Net Debt/EBITDA (TTM)

CARL0.00x

CV0.00x

Beta

CARL2.13

CV-1.80

52W Performance

CARL4.3%

CV43.3%

YTD Performance

CARL24.0%

CV-35.6%

% from 52W High

CARL-16.3%

CV-57.1%

% from 52W Low

CARL69.6%

CV50.5%

Asset Turnover (TTM)

CARL0.50x

CV0.63x

FCF Yield (TTM)

CARL-9.1%

CV-8.5%

Earnings Yield (TTM)

CARL-9.3%

CV-9.1%

Dividend Yield (TTM)

CARLN/A

CVN/A

Rule of 40

CARL-40.3

CV-232.5

EV/GP/RG

CARL0.14

CV1.78

Ticker research

View CARL research View CV research

Metric	CARL Carlsmed Inc	CV CapsoVision Inc
Market & Valuation
Market Cap	$392M	$329M
Enterprise Value	$361M	$320M
Price	$14.42	$6.59
P/E Ratio	N/A	N/A
P/S Ratio	6.19x	23.70x
EV/Sales	5.70x	23.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.62x	24.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.12x	-11.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.18x	18.89x
Revenue & Growth
Revenue (TTM)	$63M	$14M
Revenue Growth (YoY)	16.1%	-31.7%
Forward Rev Growth	40.9%	33.3%
Profitability
Gross Margin (TTM)	76.6%	50.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-60.4%	-215.5%
Net Margin (TTM)	-57.4%	-214.7%
FCF Margin (TTM)	-56.4%	-200.8%
Net Income (TTM)	$-36M	$-30M
FCF (TTM)	$-36M	$-28M
EPS (TTM)	-$1.34	-$0.60
ROE (TTM)	-3806.0%	-17785.0%
ROA (TTM)	-2896.0%	-13507.0%
ROIC (TTM)	-3278.0%	-17785.0%
Financial Health
Cash	$46M	$9M
Debt	$15M	$0
Net Cash/Debt	$31M	$9M
Current Ratio (TTM)	8.84x	3.35x
Quick Ratio (TTM)	8.32x	2.31x
Debt/Equity (TTM)	0.18x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.13	-1.80
52W Performance	4.3%	43.3%
YTD Performance	24.0%	-35.6%
% from 52W High	-16.3%	-57.1%
% from 52W Low	69.6%	50.5%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.63x
FCF Yield (TTM)	-9.1%	-8.5%
Earnings Yield (TTM)	-9.3%	-9.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-40.3	-232.5
EV/GP/RG	0.14	1.78
Ticker research	View CARL research	View CV research

Valuation

P/S Ratio

CARL

6.19x

23.70x

EV/FCF

-11.48x

CARL

-10.12x

Growth & revenue

Revenue Growth TTM

CARL

16.1%

-31.7%

Forward Revenue Growth

CARL

40.9%

33.3%

Profitability & performance

Gross Margin

CARL

76.6%

50.9%

ROE

CARL

-3806.0%

-17785.0%

FCF Yield %

-8.5%

CARL

-9.1%

52-Week Performance

43.3%

CARL

4.3%

Detailed metrics comparison

CARL

Carlsmed Inc

CapsoVision Inc

Market Cap

CARL$392M

CV$329M

Enterprise Value

CARL$361M

CV$320M

Price

CARL$14.42

CV$6.59

P/E Ratio

CARLN/A

CVN/A

P/S Ratio

CARL6.19x

CV23.70x

EV/Sales

CARL5.70x

CV23.05x

EV/EBITDA

CARL0.00x

CV0.00x

P/B Ratio

CARL4.62x

CV24.94x

P/FCF Ratio

CARLN/A

CVN/A

EV/FCF

CARL-10.12x

CV-11.48x

PEG Ratio

CARLN/A

CVN/A

Forward P/E (NTM)

CARLN/A

CVN/A

Forward P/S (NTM)

CARL4.18x

CV18.89x

Revenue (TTM)

CARL$63M

CV$14M

Revenue Growth (YoY)

CARL16.1%

CV-31.7%

Forward Rev Growth

CARL40.9%

CV33.3%

Gross Margin (TTM)

CARL76.6%

CV50.9%

Operating Margin (TTM)

CARL0.0%

CV0.0%

EBITDA Margin (TTM)

CARL-60.4%

CV-215.5%

Net Margin (TTM)

CARL-57.4%

CV-214.7%

FCF Margin (TTM)

CARL-56.4%

CV-200.8%

Net Income (TTM)

CARL$-36M

CV$-30M

FCF (TTM)

CARL$-36M

CV$-28M

EPS (TTM)

CARL-$1.34

CV-$0.60

ROE (TTM)

CARL-3806.0%

CV-17785.0%

ROA (TTM)

CARL-2896.0%

CV-13507.0%

ROIC (TTM)

CARL-3278.0%

CV-17785.0%

Cash

CARL$46M

CV$9M

Debt

CARL$15M

CV$0

Net Cash/Debt

CARL$31M

CV$9M

Current Ratio (TTM)

CARL8.84x

CV3.35x

Quick Ratio (TTM)

CARL8.32x

CV2.31x

Debt/Equity (TTM)

CARL0.18x

CV0.00x

Debt/Assets (TTM)

CARL0.0%

CV0.0%

Interest Coverage (TTM)

CARLN/A

CVN/A

Net Debt/EBITDA (TTM)

CARL0.00x

CV0.00x

Beta

CARL2.13

CV-1.80

52W Performance

CARL4.3%

CV43.3%

YTD Performance

CARL24.0%

CV-35.6%

% from 52W High

CARL-16.3%

CV-57.1%

% from 52W Low

CARL69.6%

CV50.5%

Asset Turnover (TTM)

CARL0.50x

CV0.63x

FCF Yield (TTM)

CARL-9.1%

CV-8.5%

Earnings Yield (TTM)

CARL-9.3%

CV-9.1%

Dividend Yield (TTM)

CARLN/A

CVN/A

Rule of 40

CARL-40.3

CV-232.5

EV/GP/RG

CARL0.14

CV1.78

Ticker research

View CARL research View CV research

Metric	CARL Carlsmed Inc	CV CapsoVision Inc
Market & Valuation
Market Cap	$392M	$329M
Enterprise Value	$361M	$320M
Price	$14.42	$6.59
P/E Ratio	N/A	N/A
P/S Ratio	6.19x	23.70x
EV/Sales	5.70x	23.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.62x	24.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.12x	-11.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.18x	18.89x
Revenue & Growth
Revenue (TTM)	$63M	$14M
Revenue Growth (YoY)	16.1%	-31.7%
Forward Rev Growth	40.9%	33.3%
Profitability
Gross Margin (TTM)	76.6%	50.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-60.4%	-215.5%
Net Margin (TTM)	-57.4%	-214.7%
FCF Margin (TTM)	-56.4%	-200.8%
Net Income (TTM)	$-36M	$-30M
FCF (TTM)	$-36M	$-28M
EPS (TTM)	-$1.34	-$0.60
ROE (TTM)	-3806.0%	-17785.0%
ROA (TTM)	-2896.0%	-13507.0%
ROIC (TTM)	-3278.0%	-17785.0%
Financial Health
Cash	$46M	$9M
Debt	$15M	$0
Net Cash/Debt	$31M	$9M
Current Ratio (TTM)	8.84x	3.35x
Quick Ratio (TTM)	8.32x	2.31x
Debt/Equity (TTM)	0.18x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.13	-1.80
52W Performance	4.3%	43.3%
YTD Performance	24.0%	-35.6%
% from 52W High	-16.3%	-57.1%
% from 52W Low	69.6%	50.5%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.63x
FCF Yield (TTM)	-9.1%	-8.5%
Earnings Yield (TTM)	-9.3%	-9.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-40.3	-232.5
EV/GP/RG	0.14	1.78
Ticker research	View CARL research	View CV research